Role of alveolar macrophages in pulmonary neoplasias.
Sone
S
S
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D002273:Carcinogens / Q000378:metabolism; D006168:Guinea Pigs; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008081:Liposomes; D008172:Lung Diseases, Fungal / Q000276:immunology; D008175:Lung Neoplasms / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D008222:Lymphokines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D008262:Macrophage Activation / Q000187:drug effects; D016215:Macrophage-Activating Factors; D008264:Macrophages / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D008545:Melanoma / Q000378:metabolism / Q000473:pathology; D051379:Mice; D010587:Phagocytosis; D010714:Phosphatidylethanolamines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011014:Pneumonia / Q000276:immunology; D011650:Pulmonary Alveoli / Q000473:pathology*; D051381:Rats; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D002273:Carcinogens; D008070:Lipopolysaccharides; D008081:Liposomes; D008222:Lymphokines; D016215:Macrophage-Activating Factors; D010714:Phosphatidylethanolamines; C037144:mifamurtide; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D007372:Interferons